drugset / Trial / NCT06158698

CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine

NCT06158698

RandomizedParallel-groupSingle-blindTreatment

Summary

Two-parallel groups randomized, single-blinded, multi-center phase III controlled trial in patients with chronic inflammatory cardiomyopathy to assess the efficacy of colchicine and associated prospective registry to assess the prognostic value of positive genetic testing in this population.

Timeline

Start
2023-11-14
Primary completion
2026-05-02
Completion
2028-05-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Colchicine Small molecule 0.5 mg
Subject Colchicine Small molecule 1 mg